{"id":"W4282031579","doi":"10.1038/s41391-022-00548-z","title":"The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)","year":2022,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; International Prostate Symptom Score; Lower urinary tract symptoms; Quality of life (healthcare); Urology; Prostate; Implant; Adverse effect; Hyperplasia; Sexual function; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004118893,0.0003626418,0.0006813291,0.0001391175,0.0009116243,0.00007515311,0.0002059628,0.00004224918,0.00008619719],"category_scores_gemma":[0.0001131586,0.0002171821,0.0002744671,0.0004635256,0.0003523319,0.0001473582,0.0001581665,0.0001580649,9.130897e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003398145,"about_ca_system_score_gemma":0.001217123,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001228644,"about_ca_topic_score_gemma":0.000007610507,"domain_scores_codex":[0.9971473,0.0001518318,0.000776958,0.0006149441,0.0007249516,0.0005839647],"domain_scores_gemma":[0.9979547,0.0005041569,0.0003247249,0.0006238908,0.0003022087,0.0002903408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6082444,0.02312423,0.03686577,0.01897405,0.003262442,0.0001823186,0.04348445,0.00134953,0.02527164,0.001356558,0.01093605,0.2269485],"study_design_scores_gemma":[0.2823825,0.1975326,0.113705,0.001651982,0.00650702,0.002614833,0.06953396,0.001640142,0.04409248,0.002263679,0.2753915,0.002684289],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9673653,0.01152127,0.00004993192,0.003594606,0.0008681627,0.01214192,0.004288814,0.00005624081,0.0001138073],"genre_scores_gemma":[0.9879683,0.0007454887,0.00007807595,0.0000963816,0.0002267544,0.007805322,0.0001735289,0.00007349002,0.002832677],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3258619,"threshold_uncertainty_score":0.8856427,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02132998256613281,"score_gpt":0.3113775684921714,"score_spread":0.2900475859260385,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}